In vivo gastric detection of α-synuclein inclusions in Parkinson's disease

Cited by (123)

Items 101–123 of 123

1. Examination of Abnormal Alpha-synuclein Aggregates in the Enteric Neural Plexus in Patients with Ulcerative Colitis
   Noriaki Gibo, Tomonari Hamaguchi, Yasuo Miki, Takeshi Yamamura, Masato Nakaguro, Mikako Ito, Masanao Nakamuara, Hiroki Kawashima, Masaaki Hirayama, Yoshiki Hirooka et al. · 2022 · Journal of Gastrointestinal and Liver Diseases
2. Olfactory Dysfunction as a Clinical Marker of Early Glymphatic Failure in Neurodegenerative Diseases
   Gonzalo Sánchez‐Benavides, Álex Iranzo, Oriol Grau‐Rivera, Darly Milena Giraldo, Maríateresa Buongiorno · 2025 · Diagnostics
3. Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
   Upasana Ganguly, Sukhpal Singh, Sasanka Chakrabarti, Adesh Kumar Saini, Reena Vohra Saini · 2022 · Advances in protein chemistry and structural biology
4. Gastrointestinal Biopsy Obtained During Cancer Screening, a Biological Marker for α-Synucleinopathy?
   Jelena Jotanovic, Jelena S. Milin-Lazovic, Irina I. Alafuzoff · 2022 · Journal of Neuropathology & Experimental Neurology
5. Gut Microbes in Parkinson's Disease
   Anastasia Markidi, Joshua D. Elford, Celia R. Berkers, Aletta D. Kraneveld, Paula Perez‐Pardo · 2024 · Elsevier eBooks
6. Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
   Mélanie Bourque, Marc Morissette, Amandine Isenbrandt, Silvia Giatti, Roberto Cosimo Melcangi, Manolo Carta, Roberto Frau, Marco Bortolato, Denis Soulet, Thérèse Di Paolo · 2024 · Frontiers in Neuroendocrinology
7. Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?
   Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony Tope Olofinnade, Joshua Falade, Ismail Adetayo Lawal, Olakunle J. Onaolapo · 2022 · CNS & Neurological Disorders - Drug Targets
8. Prospective cohort study of patients with early gastric cancer to detect prodromal Parkinson disease (EGC-PPD): A study protocol and baseline characteristics
   Chaewon Shin, Han‐Kwang Yang, Sung‐Hye Park, Hyukjoon Lee, Seong‐Ho Kong, Yun‐Suhk Suh, Yeon‐Ju Huh, Yun Jeong Kim, So-Yong Park, Tae‐Beom Ahn et al. · 2019 · Journal of Clinical Neuroscience
9. Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe
   Rachel Rui Yi Sim, Jeremy Lee, Joey Chieng, Ko Hui Tan, Grace Lim, Aaron Song Chuan Foo, Hei Sunny Wong, Kah Leong Lim, Kaicheng Liang · 2026 · ACS Chemical Neuroscience
10. Les synucléinopathies sont-elles des maladies à prions ?
    Marie-Laure Arotçarena, Benjamin Dehay · 2018 · Pratique Neurologique - FMC
11. Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease
    Aarti Narang, Rajat Sandhir · 2022 · Springer eBooks
12. Alpha-Synuclein as a Diagnostic Biomarker for Parkinson’s Disease
    Joakim J. E. Bergström, Martin Ingelsson · 2016 · Methods in pharmacology and toxicology
13. Parkinson’s disease – the role of the digestive tract in pathogenesis
    IKlinika Neurologiczna, Instytut Psychiatrii i Neurologii, Warszawa, Polska, Ewelina Bucior, Magdalena Konopko, IKlinika Neurologiczna, Instytut Psychiatrii i Neurologii, Warszawa, Polska, Halina Sienkiewicz‐Jarosz, IKlinika Neurologiczna, Instytut Psychiatrii i Neurologii, Warszawa, Polska · 2019 · Aktualności Neurologiczne
14. The role of the gut microbiota in Parkinson’s disease
    N I Verugina, Oleg Semenovich Levin, Elena A. Lyashenko · 2021 · S S Korsakov Journal of Neurology and Psychiatry
15. The Diagnosis of Parkinson’s Disease: Current Clinical Practice and Future Trends
    Roberto López Blanco, Álvaro Sánchez‐Ferro · 2018 · Springer eBooks
16. Parkinson fängt im Darm an
    Heinz Reichmann, Horst K.J. Baas · 2015 · DNP - Der Neurologe und Psychiater
17. Role of microbiota gut–brain axis in Parkinson's disease
    Rani Mansuri, Meenakshi Dhanawat, Shital Patel, Garima Garima, Anupama Diwan · 2025 · Elsevier eBooks
18. The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review
    Farzaneh Rafie Sedaghat, Somayeh Ahmadi, Tina Samadpour Zahmat-dar, Samira Saedi, Hossein Samadi Kafil · 2026 · Nutrition and Dietary Supplements
19. Type I Interferons Drive the Gastrointestinal Inflammatory Response in a Mouse Model of Parkinson’s Disease
    Harrison Waters, Shuyan Chen, Elizabeth Vincan, Dustin James Flanagan, Renate Schwab, Peter John Crack, Juliet Marie Taylor · 2026 · Gastro Hep Advances
20. Détection et caractérisation de l'α-synucléine dans le système nerveux entérique en conditions physiologiques et dans la maladie de Parkinson
    Anne-Gaëlle Corbillé · 2016 · theses.fr (ABES)
21. Typage moléculaire des maladies neurodégénératives dues à l’agrégation de la protéine alpha synucléine
    Alexis Fenyi · 2019 · theses.fr (ABES)
22. Parkinson’s Disease: Current Knowledge and Future Focus
    Caroline B. Pantazis, Todd Sherer, Ekemini A. U. Riley · 2026 · Springer eBooks
23. Blood-Mediated Gut–Brain Axis in Parkinson’s Disease: Focus on α-Synuclein Transport and Microbiota Dysbiosis-Induced Inflammation
    Chunjie Xu, Wei Li, Xiaonan Ma, Luyu Han, Guangxu Cui, Jingtong Zhao, Xin Wang, Yingjun Guan · 2026 · Cells